Knowledge (XXG)

Monoethanolamine oleate

Source 📝

29: 409:(closure) of the abnormal vein. It is indicated for the treatment of patients with esophageal varices that have recently bled, to prevent rebleeding. Ethanolamine is not indicated for the treatment of patients with esophageal varices that have not bled. There is no evidence that treatment of this population decreases the likelihood of bleeding. Sclerotherapy with ethanolamine has no beneficial effect upon portal hypertension, the cause of esophageal varices, so that recanalization and collateralization may occur, necessitating reinjection. 278: 255: 889: 59: 345: 426:
Toledo Hijo AA, Maximo GJ, Costa MC, Cunha RL, Pereira JF, Kurnia KA, et al. (April 2017). "Phase Behavior and Physical Properties of New Biobased Ionic Liquid Crystals".
934: 41: 963: 535: 927: 920: 92: 528: 194: 958: 953: 234: 28: 767: 521: 273: 607: 463:"Synthesis and Thermophysical Properties of Two New Protic Long-Chain Ionic Liquids with the Oleate Anion" 900: 762: 734: 406: 896: 374: 250: 109: 790: 888: 443: 904: 183: 623: 474: 435: 382: 378: 370: 290: 203: 592: 118: 277: 254: 724: 568: 544: 947: 602: 597: 587: 402: 266: 51: 143: 20: 694: 612: 582: 548: 462: 398: 72: 67: 859: 826: 757: 680: 647: 478: 864: 836: 719: 709: 662: 657: 642: 637: 557: 386: 320: 174: 439: 841: 812: 632: 492: 45: 447: 652: 577: 154: 513: 163: 831: 729: 705: 333: 129: 772: 461:Álvarez VH, Mattedi S, Martin-Pastor M, Aznar M, Iglesias M (2010). 373:
with the formula .. A colorless oily liquid, it is an example of a
223: 821: 214: 517: 239: 908: 352: 850: 810: 803: 781: 743: 703: 693: 671: 621: 566: 556: 332: 319: 289: 284: 265: 233: 213: 193: 173: 153: 128: 108: 83: 58: 40: 35: 142: 117: 928: 529: 8: 19: 935: 921: 807: 700: 563: 536: 522: 514: 276: 253: 182: 27: 202: 418: 249: 162: 97: 267: 18: 745:sclerosing agents for local injection 401:agent, it is injected topically into 50: 7: 885: 883: 71: 428:The Journal of Physical Chemistry B 222: 133: 907:. You can help Knowledge (XXG) by 14: 964:Cardiovascular system drug stubs 887: 307: 301: 381:formed by the reaction between 310: 295: 1: 100:2-Hydroxyethylammonium oleate 804:Capillary stabilising agents 479:10.1016/j.fluid.2010.08.022 52:Multum Consumer Information 980: 882: 285:Chemical and physical data 768:Sodium tetradecyl sulfate 342: 88: 26: 899:article relating to the 440:10.1021/acs.jpcb.7b01384 753:Monoethanolamine oleate 363:Monoethanolamine oleate 608:Fluocinolone acetonide 467:Fluid Phase Equilibria 367:ethanolammonium oleate 901:cardiovascular system 493:"Ethanolamine Oleate" 763:Inverted sugar syrup 735:Pentosan polysulfate 375:protic ionic liquid 23: 21:Ethanolamine Oleate 16:Pharmaceutical drug 959:Carboxylate anions 954:Ammonium compounds 791:Calcium dobesilate 393:Antivaricose agent 916: 915: 877: 876: 873: 872: 799: 798: 720:Organo-heparinoid 689: 688: 624:local anesthetics 558:Antihemorrhoidals 434:(14): 3177–3189. 360: 359: 235:CompTox Dashboard 971: 937: 930: 923: 891: 884: 808: 701: 564: 538: 531: 524: 515: 508: 507: 505: 503: 489: 483: 482: 458: 452: 451: 423: 383:monoethanolamine 371:organic compound 356: 355: 348: 327: 312: 309: 303: 297: 280: 269: 258: 257: 243: 241: 226: 206: 186: 166: 146: 136: 135: 121: 75: 54: 31: 24: 22: 979: 978: 974: 973: 972: 970: 969: 968: 944: 943: 942: 941: 880: 878: 869: 846: 795: 777: 739: 712:for topical use 685: 667: 617: 593:Fluorometholone 569:corticosteroids 560:for topical use 552: 545:Vasoprotectives 542: 512: 511: 501: 499: 491: 490: 486: 460: 459: 455: 425: 424: 420: 415: 395: 351: 349: 346:(what is this?) 343: 338:0.974 g/cm 325: 315: 306: 300: 261: 237: 229: 209: 189: 169: 149: 132: 124: 104: 101: 96: 95: 79: 17: 12: 11: 5: 977: 975: 967: 966: 961: 956: 946: 945: 940: 939: 932: 925: 917: 914: 913: 892: 875: 874: 871: 870: 868: 867: 862: 856: 854: 848: 847: 845: 844: 839: 834: 829: 824: 818: 816: 805: 801: 800: 797: 796: 794: 793: 787: 785: 779: 778: 776: 775: 770: 765: 760: 755: 749: 747: 741: 740: 738: 737: 732: 727: 725:Sodium apolate 722: 716: 714: 698: 691: 690: 687: 686: 684: 683: 677: 675: 669: 668: 666: 665: 660: 655: 650: 645: 640: 635: 629: 627: 619: 618: 616: 615: 610: 605: 600: 595: 590: 585: 580: 578:Hydrocortisone 574: 572: 561: 554: 553: 543: 541: 540: 533: 526: 518: 510: 509: 484: 453: 417: 416: 414: 411: 394: 391: 358: 357: 340: 339: 336: 330: 329: 323: 317: 316: 313: 304: 298: 293: 287: 286: 282: 281: 271: 263: 262: 260: 259: 246: 244: 231: 230: 228: 227: 219: 217: 211: 210: 208: 207: 199: 197: 191: 190: 188: 187: 179: 177: 171: 170: 168: 167: 159: 157: 151: 150: 148: 147: 139: 137: 126: 125: 123: 122: 114: 112: 106: 105: 103: 102: 99: 91: 90: 89: 86: 85: 81: 80: 78: 77: 64: 62: 56: 55: 48: 38: 37: 33: 32: 15: 13: 10: 9: 6: 4: 3: 2: 976: 965: 962: 960: 957: 955: 952: 951: 949: 938: 933: 931: 926: 924: 919: 918: 912: 910: 906: 902: 898: 893: 890: 886: 881: 866: 863: 861: 858: 857: 855: 853: 849: 843: 840: 838: 835: 833: 830: 828: 825: 823: 820: 819: 817: 815: 814: 813:bioflavonoids 809: 806: 802: 792: 789: 788: 786: 784: 780: 774: 771: 769: 766: 764: 761: 759: 756: 754: 751: 750: 748: 746: 742: 736: 733: 731: 728: 726: 723: 721: 718: 717: 715: 713: 711: 707: 702: 699: 696: 692: 682: 679: 678: 676: 674: 670: 664: 661: 659: 656: 654: 651: 649: 646: 644: 641: 639: 636: 634: 631: 630: 628: 626: 625: 620: 614: 611: 609: 606: 604: 603:Dexamethasone 601: 599: 598:Fluocortolone 596: 594: 591: 589: 588:Betamethasone 586: 584: 581: 579: 576: 575: 573: 571: 570: 565: 562: 559: 555: 550: 546: 539: 534: 532: 527: 525: 520: 519: 516: 498: 494: 488: 485: 480: 476: 472: 468: 464: 457: 454: 449: 445: 441: 437: 433: 429: 422: 419: 412: 410: 408: 404: 400: 392: 390: 388: 384: 380: 376: 372: 368: 364: 354: 347: 341: 337: 335: 331: 324: 322: 318: 294: 292: 288: 283: 279: 275: 272: 270: 268:ECHA InfoCard 264: 256: 252: 251:DTXSID8023008 248: 247: 245: 236: 232: 225: 221: 220: 218: 216: 212: 205: 201: 200: 198: 196: 192: 185: 181: 180: 178: 176: 172: 165: 161: 160: 158: 156: 152: 145: 141: 140: 138: 131: 127: 120: 116: 115: 113: 111: 107: 98: 94: 87: 82: 74: 69: 66: 65: 63: 61: 57: 53: 49: 47: 43: 39: 36:Clinical data 34: 30: 25: 909:expanding it 894: 879: 851: 811: 782: 752: 744: 704: 695:Antivaricose 672: 622: 613:Fluocinonide 583:Prednisolone 567: 500:. Retrieved 496: 487: 470: 466: 456: 431: 427: 421: 403:varicosities 399:antivaricose 396: 366: 362: 361: 350:   344:   860:Tribenoside 827:Monoxerutin 758:Polidocanol 710:heparinoids 681:Tribenoside 328: g·mol 274:100.017.163 84:Identifiers 948:Categories 865:Etamsylate 837:Troxerutin 663:Pramocaine 658:Oxetacaine 643:Benzocaine 638:Tetracaine 413:References 387:oleic acid 377:. It is a 321:Molar mass 204:U4RY8MRX7C 175:ChemSpider 110:CAS Number 93:IUPAC name 842:Hidrosmin 648:Dibucaine 633:Lidocaine 473:: 42–50. 407:sclerosis 405:to cause 119:2272-11-9 46:Drugs.com 822:Rutoside 706:heparins 653:Procaine 448:28332847 369:) is an 353:(verify) 155:DrugBank 60:ATC code 832:Diosmin 730:Heparin 697:therapy 502:7 March 334:Density 326:343.552 291:Formula 184:4445632 164:DB06689 144:5282489 130:PubChem 76:) 70: ( 68:C05BB01 773:Phenol 497:RXList 446:  397:As an 224:D02276 903:is a 895:This 852:other 783:other 673:other 905:stub 897:drug 504:2020 444:PMID 385:and 379:salt 215:KEGG 195:UNII 42:AHFS 708:or 549:C05 475:doi 471:299 436:doi 432:121 240:EPA 134:CID 73:WHO 950:: 495:. 469:. 465:. 442:. 430:. 389:. 305:41 299:20 936:e 929:t 922:v 911:. 551:) 547:( 537:e 530:t 523:v 506:. 481:. 477:: 450:. 438:: 365:( 314:3 311:O 308:N 302:H 296:C 242:) 238:( 44:/

Index


AHFS
Drugs.com
Multum Consumer Information
ATC code
C05BB01
WHO
IUPAC name
CAS Number
2272-11-9
PubChem
5282489
DrugBank
DB06689
ChemSpider
4445632
UNII
U4RY8MRX7C
KEGG
D02276
CompTox Dashboard
DTXSID8023008
Edit this at Wikidata
ECHA InfoCard
100.017.163
Edit this at Wikidata
Formula
Molar mass
Density
(what is this?)

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.